A maior rede de estudos do Brasil

Grátis
785 pág.
1 4934172924882976788

Pré-visualização | Página 22 de 50

tendientes a su obtención y expansión, (e)
definir estrategias para el uso de CT en
enfermedades genéticas, (f) determinar la
“calidad biológica” de CT de pacientes adultos
en cuanto a acumulación de daño o de
evidencias de senescencia (largo de telómeros)
y finalmente, (g) ¿será la utilización de CT en
terapias celulares un privilegio único de
pacientes de países desarrollados o será factible
implementar o transferir tecnologías para que
pacientes de países en desarrollo también se
beneficien?.
LECTURAS SUGERIDAS
Ailhaud, G. “Extracellular factors, signalling
pathways and dif ferentiation of adipose
precursor cells”. Curr Opin Cell Biol., 2:1043-
1049,1990.
Angelopoulou, M., Novelli, E., Grove, J.E.,
Rinder, H.M., Civin, C., Cheng, L., Krause, D.S.
“Cotransplantation of human mesenchymal
stem cells enhances human myelopoiesis and
megakaryocytopoiesis in NOD/SCID mice”. Exp
Hematol., 31:413-420, 2003.
Beltrami, A.P., Urbanck, K., Jajstura, J., et al.
“Evidence that human cardiac myocytes divide
after myocardial infarction”. N. Engl J Med., 344:
1750-7, 2001.
Benavente, C.A., Sierralta, W.D., Conget, P.A.,
Minguell, J.J. “Subcellular distribution and
mitogenic effect of basic fibroblast growth factor
in mesenchymal uncommitted stem cells”.
Growth Factors 21:87-94, 2003.
Bhardwaj. G., Murdoch, B., Wu, D., Baker D.P.,
Williams K.P., Chadwick K., Ling L.E., Karanu
F.N., “Bhatia M. Sonic hedgehog induces the
proliferation of primitive human hematopoietic
cells via BMP regulation”. Nat Immunol., 2:172-
180, 2001.
Bjornson, C.R., Rietze, R.L, Reynolds, B.A. et al.
« Turning brain into blood: a hematopoietic fate
adopted by adult neural stem cells in vivo”.
Science 283:534-537, 1999.
Burt, R.K., Arnold, R., Emmons, R., Oyama, Y.,
Marmont A. “Stem cell therapy for autoimmune
disease: overview of concepts from the Byrne
E, Howells DW. Stem cell therapies: a tale of
caution”. Med J Aust., 179 :164-6, 2003.
Campagnoli, C., Roberts, I.A., Campagnoli, C.,
Roberts, I.A., Kumar, S., Bennett, P.R.,
“Bellantuono I and Fisk NM. Identification of
mesenchymal stem/progenitor cells in human
first-trimester fetal blood, liver, and bone
marrow”. Blood., 98:2396-2402, 2001.
Cancedda R., Bianchi G., Derubeis A., Quarto R.
“Cell therapy for bone disease: a review of current
status”. Stem Cells., 21: 610- 6199, 2003.
Castro-Malaspina, H., Gay, R.E., Resnick, G.,
Kapoor, N., Meyers, P., Chiarieri, D., McKenzie,
S., Broxmeyer H.E. and Moore M.A.
“Characterization of human bone marrow
fibroblast colony-forming cells (CFU-F) and their
progeny”. Blood., 56:289-301, 1980.
Conget, P.A. and Minguell, J.J. “Phenotypical
and functional properties of human bone
marrow mesenchymal progenitor cells”. Journal
of Cellular Phisiology., 181:67-73, 1999.
Conget, P.A., Allers, C., Minguell, J.J. “Identification
of a discrete population of human bone marrow-
derived mesenchymalcells exhibiting properties
of uncommitted progenitors”. J Hematother
Stem Cell Res., 10(6):749-58, 2001.
75
Deans, R.J., Moseley, A.B. “Mesenchymal stem
cells: biology and potential clinical uses”. Exp
Hematol., 28 :875-884, 2000.
Digirolamo, C.M., Stokes, D., Colter, D.,
Phinney, D.G., Class, R., Prockop, D.J.
“Propagation and senescence of human marrow
stromal cells in culture: a simplecolony-forming
assay identifies samples with the greatest
potential to propagateand differentiate”.Br J
Haematol, 107:275-81, 1999.
Djouad, F., Plence, P., Bony, C., Tropel, P.,
Apparailly, F., Sany, J., Noel, D., Jorgensen, C.
“Immunosuppressive effect of mesenchymal
stem cells favors tumor growth in allogeneic
animals”. Blood., 102:3837-44, 2003.
Domen, J., Cheshier, S.H., Weissman, IL. “The
role of apoptosis in the regulation of
hematopoietic stem cells: Overexpression of
Bcl-2 increases both their number and
repopulation potential”. J Exp Med., 191:253-
264, 2000.
Ducy, P., Zhang, R., Geoffroy, V., Ridal, A.L. and
Karsenty, G. “Osf2/Cbfa1: a transcriptional
activator of osteoblast differentiation”. Cell., 89:
747-754, 1997.
Ema H., Takano H., Sudo K., Nakauchi H. “In
vitro self-renewal division of hematopoietic
stem cells”. J Exp Med.; 192:1281-1288, 2000.
Ende, N., Chen, R. “Human umbilical cord blood
cells ameliorate Huntington’s disease in
transgenic mice”. J Med., 32, 231-240, 2001.
Enver, T., Heyworth, C.M., Dexter, T.M. “Do stem
cells play dice?” Blood., 92: 348-351, 1998.
Erices, A., Conget, P., and Minguell, J.J.
“Mesenchymal progenitor cells in human
umbilical cord blood”. Br J Haematol., 109: 235-
242, 2000.
Erices, A., Conget, P., Rojas, C., Minguell, J.J.
“Gp130 activation by soluble interleukin-6
receptor/interleukin-6 enhancesosteoblastic
differentiation of human bone marrow-derived
mesenchymal stemcells”. Exp Cell Res., 280:24-
32, 2002.
Erices, A.A., Allers, C.I., Conget, P.A., Rojas, C.V.,
Minguell, J.J. “Human cord blood-derived
mesenchymal stem cells home and survive in the
marrow of immunodeficient mice after systemic
infusion”. Cell Transplant., 12:555-61, 2003.
Fernández, M., Minguell, J.J. “Adhesive
interactions in the hematopoietic system:
regulation by cytokines”. Proc Soc Exp Biol
Med., 212: 313-323, 1996.
Fernández, M., Simon V., Herrera, G., Cao
C., Del Favero, H. and Minguel l , J . J .
“Detection of stromal cells in peripheral
blood progenitor cell collections from breast
cancer patients”. Bone Marrow Transplant.,
20:265-271, 1997.
Friedenstein, A.J., Gorsaka, J.F. and Kulagina,
N.N. “Fibroblast precursors in normal and
irradiated mouse hematopoietic organs”. Exp
Hematol., 4:267-274, 1976.
Fruehauf, S., Seggewiss, R. “It’s moving day:
factors af fecting peripheral blood stem
mobi l izat ion and strategies for
improvement”. Br J Haematol., 122:360-375,
2003.
Galli, R., Borello, U., Gritti, A. et al. “Skeletal
myogenic potential of human and mouse neural
stem cells”. Nat. Neurosci., 3: 986-991, 2000.
Galmiche, M.C., Koteliansky, V.E., Briere, J.,
Herve, P. and Charrbord, P. “Stromal cells from
human long-term marrow cultures are
mesenchymal cells that differentiate following
a vascular smooth muscle dif ferentiation
pathway”. Blood., 82: 66-76, 1993.
Gori, F., Thomas, T., Hicok, K.C., Spelsberg, T.C.
and Riggs, B.L. “Dif ferentiation of human
marrow stromal precursor cells: bone
morphogenetic protein-2 increases OSF2/
CBFA1, enhances osteoblast commitment, and
inhibits late adipocyte maturation”. J Bone Miner
Res., 14:1522-1535, 1999.
Gronthos, S., Mankani, M., Brahim, J. et. al.
“Postnatal human dental pulp stem cells (DPSCs)
in vitro and in vivo”. Proc Natl Acad Sci USA.,
97: 13625-13630, 2000.
Gussoni, E., Soneoka, Y, Strickland, C.D. et al.
“Dystrophin expression in the mdx mouse
restored by stem cell transplantation”. Nature.,
401:390-39, 1999.
Hall, AK. “Stem cell is a stem cell is a stem cell”.
Cell., 33:11-12, 1983.
Herzog, EL, Chai, L, Krause, DS. “Plasticity of
marrow-derived stem cells”. Blood., 102:3483-
3493, 2003.
76
Hirai, H. “Stem cells and regenerative
medicine”. Hum Cell., 15:190-198, 2002.
Huang, S., Law, P., Francis, K., Palsson, B.O.,
Ho, A.D. “Symmetry of initial cell divisions
among primitive hematopoietic progenitors is
independent of ontogenic age and regulatory
molecules” Blood., 94:2595-2604, 1999.
Ikehara, S., “Treatment of autoimmune diseases
by hematopoietic stem cells transplantation”.
Exp. Hematol., 29: 661-669, 2001.
Ito, T., Suzuki, A., Imai, E., Okabe, M., Hori, M.
“Bone marrow is a reservoir of repopulating
mesangial cells during glomerular remodeling”.
J Am Soc Nephrol., 12:2625-35, 2001.
Jackson, K.A., Mi, T., Goodell, M.A.
“Hematopoietic potential of stem cells isolated
from murine skeletal muscle”. Proc. Natl. Acad,
Sci. USA., 96: 14482- 14486, 1999.
Johansson, C.B. “Mechanism of stem cells in
the central nervous system”. J Cell